Dr. Jeffrey M. Stewart
Claim this profileGarnet Health Medical Center
Studies Prostate Cancer
Studies Lung Cancer
14 reported clinical trials
29 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
BRCA1 positive
BRCA2 positive
2Lung Cancer
Stage III
Stage IV
Stage I
Affiliated Hospitals
Clinical Trials Jeffrey M. Stewart is currently running
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting1 award Phase 219 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
More about Jeffrey M. Stewart
Clinical Trial Related5 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Jeffrey M. Stewart has experience with
- Pembrolizumab
- Carboplatin
- Durvalumab
- Intensity-Modulated Radiation Therapy (IMRT)
- Stereotactic Body Radiation Therapy (SBRT)
- Imatinib Mesylate
Breakdown of trials Jeffrey M. Stewart has run
Prostate Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey M. Stewart specialize in?
Jeffrey M. Stewart focuses on Prostate Cancer and Lung Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Jeffrey M. Stewart currently recruiting for clinical trials?
Yes, Jeffrey M. Stewart is currently recruiting for 5 clinical trials in Middletown New York. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey M. Stewart has studied deeply?
Yes, Jeffrey M. Stewart has studied treatments such as Pembrolizumab, Carboplatin, Durvalumab.
What is the best way to schedule an appointment with Jeffrey M. Stewart?
Apply for one of the trials that Jeffrey M. Stewart is conducting.
What is the office address of Jeffrey M. Stewart?
The office of Jeffrey M. Stewart is located at: Garnet Health Medical Center, Middletown, New York 10940 United States. This is the address for their practice at the Garnet Health Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.